Zobrazeno 1 - 10
of 141
pro vyhledávání: '"J. Haustein"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sylvia H. Heywang-Köbrunner, R. Beck, M. Untch, J. Haustein, C. Pohl, B. Lommatzsch, W. B. J. Nathrath
Publikováno v:
Radiology. 191:639-646
PURPOSE: To optimize detection and diagnosis of breast lesions with contrast-enhanced magnetic resonance (MR) imaging. MATERIALS AND METHODS: A three-dimensional fast low-angle shot pulse sequence was used for a group comparison consisting of 76 high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f03508358c4e8f402337676a035edd
https://doi.org/10.1148/radiology.191.3.8184040
https://doi.org/10.1148/radiology.191.3.8184040
Autor:
J Haustein, T Louton, J. Planitzer, M. F. Reiser, Wolfgang Schörner, M Schöffel, Michael Laniado, Beck W, W Kaiser, H P Niendorf
Publikováno v:
Radiology. 186:855-860
To investigate the safety, patient tolerance, and efficacy with 0.3 mmol/kg gadopentetate dimeglumine in magnetic resonance (MR) imaging of the central nervous system (CNS), a phase 3 trial was conducted in 199 patients with suspected CNS lesions. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e586205ab3d250a8663d7c5ad3d4fc7
https://doi.org/10.1148/radiology.186.3.8430199
https://doi.org/10.1148/radiology.186.3.8430199
Autor:
J. Haustein, R. Götz, U. Klemenz, Klaus Lackner, E. Heidbreder, Th. Krahe, G. Schuhmann-Giampieri, P. Landwehr
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 156:523-526
MRT with gadolinium-DTPA (0.1 mmol/kg body weight) was performed in 10 patients with renal insufficiency requiring dialysis and the clearance of gadolinium-DTPA was studied. After 3 dialysis on 3 successive days more than 97% of the initial concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc92d3b6d9db28aaa9d6a18807a14cba
https://doi.org/10.1055/s-2008-1032936
https://doi.org/10.1055/s-2008-1032936
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 156:382-387
The aim was to validate the MRI assessment of regional cerebral blood flow. Measurements were performed on a 1.5 T imaging system using a fast T2*-weighted gradient-echo sequence. After intravenous injection of gadolinium-DTPA 30 images were acquired
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac12869254b3977e177a84e2e87968f9
https://doi.org/10.1055/s-2008-1032905
https://doi.org/10.1055/s-2008-1032905
Autor:
G. Schuhmann-Giampieri, W. Clauß, B. Stöckl, J. Haustein, G. Friedman, K. R. R. Neufang, G. P. Krestin
Publikováno v:
European Radiology. 2:16-23
Renal elimination of the paramagnetic contrast agent Gadolinium-DTPA (Gd-DTPA) was analyzed in 24 patients with impaired renal function and 3 normal controls. Dynamic magnetic resonance studies were performed using fast gradient-echo sequences with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81bdb14093ce5351278a2e2897d11aff
https://doi.org/10.1007/bf00714176
https://doi.org/10.1007/bf00714176
Publikováno v:
Magnetic Resonance in Medicine. 22:222-228
This review reports data on the general and renal tolerance of the paramagnetic contrast agent Gd-DTPA after intravenous administration. Gd-DTPA was administered usually at a dose level of 0.1-0.2 mmol/kg body wt (range: 0.005-0.25 mmol/kg body wt) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776033d080ecf34467b0c34e31b57ea8
https://doi.org/10.1002/mrm.1910220212
https://doi.org/10.1002/mrm.1910220212
Publikováno v:
European Journal of Radiology. 13:15-20
Gd-DTPA is the first paramagnetic contrast agent approved for clinical use in cranial and spinal MRI in the F.R.G., U.S.A., Japan and several other countries. After submission 13439 patients were enrolled in standardized protocolled clinical trials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba5b6f39d022c3b49f5f0c37198b438
https://doi.org/10.1016/0720-048x(91)90049-2
https://doi.org/10.1016/0720-048x(91)90049-2
Autor:
J C, Böck, B, Sander, J, Hierholzer, J, Haustein, M, Scholz, K H, Radke, W, Schörner, W, Lanksch, R, Felix
Publikováno v:
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 157(4)
We compared the value of gadolinium-enhanced first-pass MRI perfusion studies and HMPAO-SPECT for the assessment of regional cerebral blood flow in a prospective study of 23 intracranial tumour patients. In five tumours with homogeneous hypoperfusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10438e5ccec81de4bf21f40323c022c2
https://pubmed.ncbi.nlm.nih.gov/1391841
https://pubmed.ncbi.nlm.nih.gov/1391841
Publikováno v:
AJNR Am J Neuroradiol
PURPOSE: To investigate the efficacy of 0.025, 0.05 and 0.1 mmol/kg gadopentetate dimeglumine in MR imaging of patients with intracranial tumors at mid and high field strength. METHODS: In 88 patients, an open-label phase III multicenter dose-finding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8c6ab0dd9a23985b2649e723a79393b
https://pubmed.ncbi.nlm.nih.gov/1636537
https://pubmed.ncbi.nlm.nih.gov/1636537